Journal of Affective Disorders
Volume 83, Issue 1 , Pages 79-82 , 15 November 2004

Aberration of cholesterol level in first-onset bipolar I patients

Received 5 January 2004 ,Revised 30 April 2004 ,Accepted 30 April 2004.

References 

  1. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin. Chem. 1974;20:470–475
  2. Atmaca M, Kuloglu M, Tezcan E, Ustundag B, Bayik Y. Serum leptin and cholesterol levels in patients with bipolar disorder. Neuropsychobiology. 2002;46:176–179
  3. Bocchetta A, Chillotti C, Severino G, Ardau R, Del Zompo M. Carbamazepine augmentation in lithium-refractory bipolar patients: a prospective study on long-term prophylactic effectiveness. J. Clin. Psychopharmacol. 1997;17:92–96
  4. Cassidy F, Carroll BJ. Hypocholesterolemia during mixed manic episodes. Eur. Arch. Psychiatry Clin. Neurosci. 2002;252:110–114
  5. Diebold K, Michel G, Schweizer J, Diebold-Dorsam M, Fiehn W, Kohl B. Are psychoactive-drug-induced changes in plasma lipid and lipoprotein levels of significance for clinical remission in psychiatric disorders?. Pharmacopsychiatry. 1998;31:60–67
  6. Ghaemi SN, Shields GS, Hegarty JD, Goodwin FK. Cholesterol levels in mood disorders: high or low?. Bipolar Disord. 2000;2:60–64
  7. Glueck CJ, Tieger M, Kunkel R, Hamer T, Tracy T, Speirs J. Hypocholesterolemia and affective disorders. Am. J. Med. Sci. 1994;308:218–225
  8. Guillem E, Pelissolo A, Notides C, Lepine JP. Relationship between attempted suicide, serum cholesterol level and novelty seeking in psychiatric in-patients. Psychiatry Res. 2002;112:83–88
  9. Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. Rockville, MD: National Institute of Mental Health; 1976;DHEW Pub. No. (ADM) 76–338
  10. Ormiston T, Wolkowitz OM, Reus VI, Manfredi F. Behavioral implications of lowering cholesterol levels: a double-blind pilot study. Psychosomatics. 2003;44:412–414
  11. Pozzi F, Troisi A, Cerilli M, Autore AM, Lo Castro C, Ribatti D, et al. Serum cholesterol and impulsivity in a large sample of healthy young men. Psychiatry Res. 2003;120:239–245
  12. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry. 1998;59(Suppl. 20):22–33
  13. Swartz CM. Albumin decrement in depression and cholesterol decrement in mania. J. Affect. Disord. 1990;19:173–176
  14. Tanskanen A, Vartiainen E, Tuomilehto J, Viinamaki H, Lehtonen J, Puska P. High serum cholesterol and risk of suicide. Am. J. Psychiatry. 2000;157:648–650
  15. Vevera J, Zukov I, Morcinek T, Papezova H. Cholesterol concentrations in violent and non-violent women suicide attempters. Eur. Psychiatry. 2003;18:23–27
  16. Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J. Clin. Psychiatry. 2003;64:663–667
  17. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry. 1978;133:429–435

PII: S0165-0327(04)00174-0

doi: 10.1016/j.jad.2004.04.010

Journal of Affective Disorders
Volume 83, Issue 1 , Pages 79-82 , 15 November 2004

Article Tools